Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to see the effects of non-invasive vagal nerve stimulation for the reduction in frequency of seizure associated with epilepsy in subjects 18 or older.


Clinical Trial Description

The purpose of the study is to determine the effects of non-invasive vagus nerve stimulation for the reduction in frequency of seizure associated with epilepsy in subjects 18 or older. Subjects will record 4 weeks of baseline seizure activity before being randomized for a period of 8 weeks to receive and active treatment to an active-sham treatment. All subjects will then receive another 8 weeks of active treatment. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01910129
Study type Interventional
Source ElectroCore INC
Contact
Status Terminated
Phase N/A
Start date July 2013
Completion date October 2014

See also
  Status Clinical Trial Phase
Completed NCT00021866 - Developmental Effects On Children Of Women Who Take Antiepileptic Drugs During Pregnancy N/A
Completed NCT01417507 - Natural History of Brain Function, Quality of Life, and Seizure Control in Patients With Brain Tumor Who Have Undergone Surgery N/A
Completed NCT01123746 - Utility of Laboratory Testing for Children With Seizure in Emergency Department N/A
Completed NCT02926703 - Lactate Compared to Creatine Kinase as Diagnostic Marker in Generalized Epileptic Seizure N/A
Completed NCT01796574 - Ketogenic Diet for Refractory Status Epilepticus N/A
Not yet recruiting NCT01436695 - Safety and Feasibility of Using Epicall for Monitoring Pre-seizure Biomarkers N/A
Recruiting NCT05746624 - Procedural Motor Memory in Long COVID-19 N/A
Terminated NCT02883712 - Study of Predictors of Response to Anti Epilepsy in Epilepsy
Completed NCT00880204 - Evaluation of Essential Surgical Skills-Emergency Maternal and Child Health Training N/A
Enrolling by invitation NCT02694094 - Impact of Ketogenic Diets on Cardiovascular Health in Adults With Epilepsy
Completed NCT02426047 - Medium Chain Triglycerides as an Adjunct to the Modified Atkins Diet for Women With Catamenial Epilepsy N/A
Completed NCT01744301 - Acid Suppressing Drug Seizure Epidemiology Study N/A
Completed NCT01834482 - Modified Atkins Diet Plus KetoCal for Adult Epilepsy N/A
Completed NCT00946751 - To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions Phase 1
Completed NCT01694524 - Nervous System Infections Among Patients With Febrile Seizure N/A
Completed NCT00298532 - OPALS Pediatric Study N/A
Completed NCT01982812 - A Dose-Escalation, Safety and Feasibility Study of Enteral LVT for Seizure Control in Pediatric CM Phase 2
Completed NCT01660672 - Enteral Levetiracetam For Seizure Control In Pediatric Cerebral Malaria Phase 1/Phase 2
Completed NCT00285285 - Point of Care Device Use in the Pediatric Emergency Department N/A
Completed NCT01801072 - Seizure Prophylaxis in Aneurysm Repair Phase 4